http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002004030-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1241 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12 |
| filingDate | 2001-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f62068ae8eff8a08c1f628dc6c47be5 |
| publicationDate | 2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002004030-A1 |
| titleOfInvention | Extracorporal system for treating disease with radionucleotides |
| abstract | A composition of matter comprises a pathogen-targeting organic moiety which is conjugated to a radioisotope which has a half-life of less than 100 days. The composition can be synthesized by bringing together a radioisotope having a half life of less than 100 days with a greater than stoichiometric amount of a complexing agent so as to form a first mixture containing a reaction product between the radioisotope and the complexing agent; removing the excess complexing agent from the mixture; and bringing together the first reaction product and an antibody substance so as to form a second mixture containing a reaction product between the first reaction product and the antibody substance. The composition is deposited on a particulate substrate and is useful for treating infectious diseases caused by pathogens by passing the patients blood through a bed formed from the particles. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008080302-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7314460-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6969367-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005059921-A1 |
| priorityDate | 1998-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.